October 30, 2024 – BD declares Well being Canada approval of the BD Onclarity™ HPV Assay for human papillomavirus (HPV) testing to be used with self-collected at-home vaginal specimens. Self-collected samples present a substitute for the standard Pap smear, carried out by a health care provider with a speculum, making cervical most cancers screening extra accessible.

In comparison with the standard Pap smear, self-collection of HPV is much less invasive, cheaper and requires much less frequent testing, which is now beneficial each 5 years. The accuracy of self-collection for HPV is on par with that of physician-collected samples, making cervical most cancers prevention extra accessible, particularly for distant, rural, and susceptible populations. That is crucial because the incidence of cervical most cancers is 3 times increased in underserved populations in distant communities which have restricted entry to screening in comparison with the final inhabitants.

Proceed studying